PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
142 hedge funds and large institutions have $415M invested in Progenics Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
Holders
142
Holding in Top 10
–
Calls
$2.69M
Puts
$1.16M
Top Buyers
| 1 | +$8.28M | |
| 2 | +$6.05M | |
| 3 | +$4.42M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$3.92M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$2.47M |
Top Sellers
| 1 | -$4.73M | |
| 2 | -$3.88M | |
| 3 | -$3.73M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.84M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.83M |